APA Zitierstil

Navalkele, B. D., & Chopra, T. (2018). Bezlotoxumab: An emerging monoclonal antibody therapy for prevention of recurrent Clostridium difficile infection. Biologics.

Chicago Zitierstil

Navalkele, Bhagyashri D., und Teena Chopra. "Bezlotoxumab: An Emerging Monoclonal Antibody Therapy for Prevention of Recurrent Clostridium Difficile Infection." Biologics 2018.

MLA Zitierstil

Navalkele, Bhagyashri D., und Teena Chopra. "Bezlotoxumab: An Emerging Monoclonal Antibody Therapy for Prevention of Recurrent Clostridium Difficile Infection." Biologics 2018.

Achtung: Diese Zitate sind unter Umständen nicht zu 100% korrekt.